Unlocking the pathways of endocrine resistance

Date 07 October 2016
Event ESMO 2016 Congress
Session New developments in the management of ER-positive metastatic breast cancer
Topics Cytotoxic agents
Breast Cancer
Therapy
Biological therapy
Presenter Giuseppe Curigliano
Authors G. Curigliano
  • Drug Development, Istituto Europeo di Oncologia, 20141 - Milano/IT